Albert Bourla, Pfizer CEO (Evan Vucci, AP Images)

Covid-19 roundup: Pfiz­er sub­mits EUA for Omi­cron-tar­get­ed boost­er; No­vavax EUA ex­pands to teens

The Omi­cron-tar­get­ed boost­ers are com­ing. Al­most 250 days since Omi­cron be­came the dom­i­nant vari­ant in the US, Pfiz­er and BioN­Tech on Mon­day of­fi­cial­ly an­nounced that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.